CHAPTER 10: DERMATOLOGY

Points to be covered in this topic

❖ DERMATOLOGY
❖ PSORIASIS
❖ SCABIES
❖ ECZEMA
➤ Definition
➤ Etiopathogenesis
➤ Clinical Manifestation
➤ Diagnosis of Eczema
➤ Nonpharmacological and pharmacological management

10.1 DERMATOLOGY
10.1.1 Introduction
Dermatology is a medical specialty focused on the diagnosis, treatment, and
prevention of conditions related to the skin, hair, nails, and mucous membranes.
Dermatologists are medical doctors who specialize in dermatology and are trained
to address a wide range of dermatological issues, from common skin conditions to
complex disorders. The field encompasses both medical and cosmetic aspects of
skin health.
✓ Here are some key aspects of dermatology:
1. Skin Conditions: Dermatologists diagnose and treat various skin conditions,
including but not limited to:
• Acne
• Eczema (Dermatitis)
• Psoriasis
• Skin Infections (Bacterial, Fungal, Viral)
• Rosacea
• Skin Allergies
• Skin Cancer

2. Hair and Scalp Disorders: Dermatologists evaluate and manage conditions

affecting the hair and scalp, such as alopecia (hair loss), dandruff,
and fungal infections.
3. Nail Disorders: Conditions affecting the nails, including fungal
infections, ingrown toenails, and nail psoriasis, fall within the scope
of dermatology.
4. Cosmetic Dermatology: Dermatologists perform
cosmetic procedures to enhance the appearance of the skin,
reduce signs of aging, and address aesthetic concerns.
Procedures may include Botox injections, dermal fillers,
chemical peels, laser therapy, and more.
5. Mohs Surgery: Dermatologists skilled in Mohs surgery
perform a precise surgical technique to remove skin
cancers layer by layer, minimizing damage to healthy
tissue. It is often used for basal cell carcinoma and
squamous cell carcinoma.
6. Pediatric Dermatology: Dermatologists specializing in
pediatric dermatology focus on skin conditions affecting
infants, children, and adolescents, including eczema,
birthmarks, and genetic skin disorders.
7. Sexually Transmitted Infections (STIs): Dermatologists may diagnose and treat
skin manifestations of STIs, such as genital warts, herpes, and syphilis.
8. Patch Testing: Dermatologists may perform patch testing to identify allergens
responsible for contact dermatitis.
9. Immunodermatology: This branch involves the study of skin disorders with an
immunological basis, including autoimmune skin diseases like lupus erythematosus
and bullous pemphigoid.
10. Teledermatology: With advancements in technology, dermatologists may
provide remote consultations and assessments through teledermatology platforms.
11. Preventive Measures: Dermatologists educate patients about sun protection to
prevent skin cancers and promote overall skin health.
10.2 PSORIASIS
10.2.1 Introduction
Psoriasis is a chronic autoimmune skin condition
characterized by the rapid buildup of skin cells, leading
to the formation of thick, scaly patches on the skin's
surface. It is a non-contagious disorder that can affect
people of all ages, and its severity can vary from mild to
severe. Psoriasis is not just a skin condition; it can also
affect joints, leading to a form of arthritis known as psoriatic arthritis.

✓ Key Features of Psoriasis:

1. Skin Lesions:
Plaques: The most common manifestation of psoriasis is the development of raised,
red patches of skin covered with silvery-white scales. These patches are known as
plaques.
Scalp Involvement: Psoriasis can affect the scalp, leading to the formation of scales
or red patches. It may resemble dandruff.
2. Distribution of Lesions: Psoriasis lesions can occur on any part of the body, but
common sites include the elbows, knees, lower back, and scalp.
Nail involvement is also common.
3. Itching and Discomfort: Psoriasis plaques can be itchy and
may cause discomfort or pain, especially if they crack or bleed.
4. Psoriatic Arthritis: In some individuals, psoriasis is associated
with joint inflammation, leading to psoriatic arthritis. This can
result in joint pain, stiffness, and swelling.
5. Chronic and Recurrent: Psoriasis is a chronic condition characterized by periods
of exacerbation and remission. Flare-ups can be triggered by various factors,
including stress, infections, and certain medications.
6. Immune System Involvement: Psoriasis is considered an
autoimmune disease where the immune system mistakenly attacks
healthy skin cells, leading to the accelerated growth of skin cells.
7. Genetic Predisposition: There is a genetic component to psoriasis, and
individuals with a family history of the condition may be at a higher risk.
8. Triggers and Aggravating Factors: Factors such as stress, infections, certain
medications, and environmental factors can trigger or exacerbate psoriasis.
9. Inverse Psoriasis: Inverse psoriasis affects areas where skin surfaces touch or rub
together, such as the armpits, groin, and under the breasts. It appears as smooth, red
lesions.
10. Pustular Psoriasis: A less common form of psoriasis characterized by the
presence of small, pus-filled blisters. It can be localized or
widespread.
✓ Impact on Quality of Life:
Psoriasis not only affects the physical health of individuals but also has a
significant impact on their emotional well-being and quality of life. The visibility of
skin lesions can lead to self-consciousness and may result in social and
psychological challenges.
✓ Here are key aspects of the etiopathogenesis of psoriasis:
1. Genetic Predisposition: Psoriasis has a strong genetic component, and a family
history of the condition increases the risk of developing psoriasis.
Specific genetic markers, such as variations in certain genes like HLA-C and
others, have been associated with an increased susceptibility to psoriasis.
2. Immune System Dysregulation: Psoriasis is considered an autoimmune disorder,
and immune system dysregulation plays a central role in its pathogenesis.
T cells, a type of white blood cell, are activated inappropriately in psoriasis. In
particular, CD4+ and CD8+ T cells play a role in the inflammatory response.
3. Keratinocyte Proliferation: The interaction between immune cells and
keratinocytes (skin cells) is dysregulated in psoriasis. Activated T cells release
cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukins, which
stimulate the rapid proliferation of keratinocytes.
4. Abnormal Epidermal Differentiation: In normal skin, the process of epidermal
differentiation is well-regulated. In psoriasis, this process is disrupted, leading to
the formation of thickened skin and scales.
There is an accelerated turnover of skin cells, with cells moving from the basal
layer to the surface in a matter of days instead of weeks.
5. Inflammatory Cytokines: Several proinflammatory cytokines are elevated in
psoriatic skin lesions. These include TNF-alpha, interleukin-17 (IL-17), and
interleukin-23 (IL-23).
IL-17, in particular, plays a crucial role in promoting inflammation and triggering
the release of other inflammatory mediators.
6. Vascular Changes: Psoriasis is associated with changes in blood vessels within
the skin. The increased vascularization contributes to the redness and warmth
observed in psoriatic plaques.
7. Environmental Triggers: Environmental factors, such as stress, infections
(especially streptococcal infections), and certain medications (e.g., beta-blockers,
lithium), can trigger or exacerbate psoriasis in individuals with a genetic
predisposition.
8. Psoriatic Arthritis: Psoriatic arthritis, which affects some individuals with
psoriasis, involves inflammation of the joints. The mechanisms underlying psoriatic
arthritis are similar to those involved in skin inflammation.
9. Complex Interactions: The pathogenesis of psoriasis involves complex
interactions between immune cells, keratinocytes, and various signaling pathways.
Multiple pathways, including the NF-kappa B pathway, contribute to the
inflammatory response.
Understanding these underlying mechanisms has led to the development of targeted
therapies that specifically address key components of the immune response in
psoriasis. Biologic medications, such as those targeting TNF-alpha, IL-17, and IL-
23, have shown efficacy in managing psoriasis by modulating the immune system's
aberrant responses. These advancements have improved treatment options for
individuals with psoriasis, offering more targeted and effective therapies.
10.2.3 Clinical Manifestations
Psoriasis is a chronic skin condition with various clinical manifestations that can
affect the skin, nails, and joints. The specific features can vary among individuals,
but common clinical manifestations include:
1. Plaque Psoriasis:
Description: Plaque psoriasis is the most common form,
characterized by the development of raised, red plaques
covered with silvery-white scales.
Distribution: Plaques often appear on the elbows, knees,
lower back, and scalp. They can also occur on other
parts of the body.
2. Guttate Psoriasis:
Description: Guttate psoriasis presents as small, red,
drop-like lesions scattered across the skin.
Trigger: Often triggered by bacterial infections, such
as streptococcal throat infections.
3. Pustular Psoriasis:
Description: Pustular psoriasis is characterized by the
presence of small, pus-filled blisters (pustules) on red
skin.
Types: There are different types, including localized and generalized pustular
psoriasis.
4. Inverse Psoriasis:
Description: Inverse psoriasis affects skin folds, appearing as
smooth, red lesions without scales.
Common Areas: Common sites include the armpits, groin,
under the breasts, and genital areas.
5. Erythrodermic Psoriasis:
Description: Erythrodermic psoriasis is a severe and rare form
characterized by widespread redness and scaling of the skin.
Complications: It can be associated with systemic symptoms
and is considered a medical emergency.
6. Nail Psoriasis:
Features: Psoriasis can affect the nails, causing changes such
as pitting, discoloration, thickening, and separation from the
nail bed (onycholysis).
Severity: Nail involvement can vary from mild to severe.
7. Scalp Psoriasis:
Features: Psoriasis can affect the scalp, leading to red patches
covered with silvery scales. It may resemble dandruff.
Hair Loss: Severe cases may result in hair loss in affected areas.
8. Psoriatic Arthritis:
Joint Inflammation: Psoriatic arthritis is a common comorbidity, involving
inflammation of the joints.
Symptoms: Joint pain, stiffness, swelling, and deformities can
occur.
9. Koebner Phenomenon:
Description: The Koebner phenomenon refers to the
development of psoriatic lesions in areas of skin trauma or
injury.
Common Triggers: Cuts, scrapes, or sunburn can trigger this response.
10. Pruritus and Discomfort:
Itching: Psoriasis plaques can be intensely itchy, leading to discomfort.
Pain: In some cases, psoriasis lesions may cause pain, especially if they crack or
bleed.

11. Psychosocial Impact: Psoriasis can have a significant impact on an individual's

quality of life, leading to psychological challenges, self-consciousness, and social
stigma.
10.2.4 Diagnosis of Psoriasis
The diagnosis of psoriasis is typically made based on a combination of clinical
evaluation, medical history, and, in some cases, additional tests. Dermatologists,
who specialize in skin disorders, are usually involved in the diagnosis and
management of psoriasis. Here are the key steps in the diagnosis of psoriasis:
1. Clinical Examination: A dermatologist will conduct a
thorough physical examination of the skin, nails, and sometimes
the scalp. Psoriasis has characteristic features, including the
presence of raised, red plaques with silvery-white scales.
2. Medical History: The dermatologist will inquire about the patient's medical
history, including the onset and duration of symptoms, family history of psoriasis or
other skin conditions, and any potential triggers or aggravating factors.
3. Psoriasis Subtypes: Psoriasis can manifest in different subtypes, and the
dermatologist will assess whether the patient's presentation fits one or more of these
subtypes, such as plaque psoriasis, guttate psoriasis, pustular psoriasis, or inverse
psoriasis.
4. Nail and Scalp Examination: Examination of the nails for changes such as
pitting, discoloration, or separation from the nail bed may provide additional clues.
Scalp involvement, which can resemble dandruff or lead to plaques, is also
assessed.

5. Biopsy (Rarely): In some cases, a skin biopsy may be performed, especially if

the diagnosis is unclear or if there is a need to rule out other skin conditions. A
small sample of skin tissue is taken and examined under a microscope.
6. Rule Out Other Conditions: Psoriasis may resemble other skin disorders, and it's
important to rule out conditions such as eczema, seborrheic dermatitis, or fungal
infections. The clinical features and, if necessary, biopsy results help in
distinguishing psoriasis from other conditions.
7. Psoriatic Arthritis Assessment: For individuals with joint symptoms, the
dermatologist may collaborate with a rheumatologist to assess for psoriatic arthritis.
Joint pain, stiffness, and swelling may indicate involvement of the joints.
8. Scoring Systems: In some cases, dermatologists use scoring systems, such as the
Psoriasis Area and Severity Index (PASI), to assess the extent and severity of
psoriasis lesions. This helps in monitoring changes over time and guiding treatment
decisions.
The diagnosis of psoriasis is primarily clinical, and no specific blood test or
imaging study is required for routine cases. However, additional tests may be
ordered if there are specific concerns or if there is a need to assess the impact of
psoriasis on other organs.
10.2.5 Nonpharmacological and Pharmacological Management
The management of psoriasis involves a combination of nonpharmacological
(lifestyle and skincare practices) and pharmacological (medication-based)
approaches. The goal is to control inflammation, alleviate symptoms, prevent flare-
ups, and improve the quality of life for individuals with psoriasis.
Here's an overview of both nonpharmacological and pharmacological management
strategies:
✓ Nonpharmacological Management:
1. Topical Moisturization: Regular use of emollients and moisturizers helps keep
the skin hydrated, reducing dryness and scaling.
2. Avoiding Triggers: Identifying and avoiding specific triggers that worsen
psoriasis symptoms, such as stress, infections, and certain medications.
3. Sun Exposure: Limited exposure to natural sunlight can be beneficial for some
individuals with psoriasis. However, it's essential to avoid overexposure and use
sun protection.
4. Balanced Diet: Maintaining a balanced and healthy diet may contribute to overall
well-being. Some individuals find that certain dietary modifications, such as
reducing alcohol consumption and avoiding trigger foods, can be helpful.
5. Stress Management: Stress reduction techniques, such as mindfulness,
meditation, and yoga, can be beneficial, as stress is a known trigger for psoriasis
flare-ups.
6. Avoiding Trauma to the Skin: Preventing skin injuries or trauma can help avoid
the Koebner phenomenon, where new psoriatic lesions develop in areas of skin
trauma.
7. Salt Baths and Dead Sea Salts: Adding Dead Sea salts or Epsom salts to
bathwater may help soothe the skin and reduce scaling.
8. Avoiding Smoking: Smoking is associated with a higher risk of developing
psoriasis and may worsen existing symptoms. Quitting smoking is beneficial for
overall health.
Pharmacological Management:
1. Topical Therapies: Topical corticosteroids, vitamin D analogs (calcipotriol), coal
tar, salicylic acid, and calcineurin inhibitors may be used depending on severity and
site of lesions.
2. Phototherapy (Light Therapy):
UVB Phototherapy: Exposure to ultraviolet B (UVB) light under medical
supervision can help reduce inflammation.
PUVA Therapy: Psoralen combined with UVA light (PUVA) is another form of
phototherapy.
3. Systemic Medications:
Oral Retinoids: Retinoids derived from vitamin A, such as acitretin, may be
prescribed for severe cases.
Methotrexate: An immunosuppressive medication that can be effective for
moderate to severe psoriasis.
Cyclosporine: Immunosuppressive drug used for severe psoriasis, typically for
short periods due to potential side effects.
Biologic Therapies: Targeted biologic drugs, including TNF-alpha inhibitors (e.g.,
etanercept, adalimumab), IL-17 inhibitors (e.g., secukinumab, ixekizumab), and IL-
23 inhibitors (e.g., ustekinumab), are effective for moderate to severe psoriasis.
4. Systemic Retinoids:
Acitretin: An oral retinoid that can be used for severe psoriasis.
5. Newer Therapies:
Janus Kinase (JAK) Inhibitors: Emerging oral medications that target the JAK
pathway, such as tofacitinib, are being investigated for psoriasis.
6. Biologics for Psoriatic Arthritis: For individuals with psoriatic arthritis,
medications such as TNF-alpha inhibitors (e.g., adalimumab, etanercept), IL-17
inhibitors, and IL-12/23 inhibitors (e.g., ustekinumab) may be used.
7. Combination Therapies: Dermatologists may use a combination of treatments,
such as combining topical therapies with phototherapy or systemic medications.

10.3 SCABIES
10.3.1 Introduction
Scabies is a highly contagious parasitic infestation of the skin caused by the
microscopic mite Sarcoptes scabiei. This condition is characterized by intense
itching and the formation of small, raised, and often linear burrows on the skin.
Scabies is a global health concern, affecting people of all ages, socioeconomic
backgrounds, and regions. The mite responsible for scabies is transmitted through
close personal contact, and outbreaks can occur in various settings, including
households, healthcare facilities, and crowded living conditions.
The female scabies mite burrows into the top layer of the
skin, where it lays eggs and produces feces, triggering an
allergic reaction that leads to the classic symptoms of
scabies. The hallmark sign is severe itching, particularly
at night, when the mites are most active. Scratching the
affected areas can result in secondary bacterial
infections.
Scabies is not only a physical health concern but also has
significant social and emotional implications due to its
association with stigma and misconceptions about
personal hygiene.
Prompt diagnosis and appropriate treatment are crucial to
alleviate symptoms, prevent the spread of infestation,
and address potential complications.
The management of scabies typically involves topical or oral medications to
eliminate the mites and their eggs. Additionally, measures such as washing clothes
and bedding, thorough cleaning of living spaces, and treatment of close contacts are
essential to prevent reinfestation.
While scabies is a treatable condition, its impact extends beyond the physical
symptoms, emphasizing the importance of public health education, early detection,
and comprehensive management strategies to reduce the burden of scabies in
communities worldwide.
10.3.2 Etiopathogenesis of Scabies
• The etiopathogenesis of scabies involves understanding the causes and
mechanisms underlying the development of the condition. Scabies is primarily
caused by infestation with the Sarcoptes scabiei mite.
✓ Causative Agent:
1. Sarcoptes scabiei Mite: The primary cause of scabies is the microscopic mite
Sarcoptes scabiei. This mite is a parasitic arthropod that burrows into the outer
layer of the skin, where it lays eggs and causes an inflammatory response.
2. Life Cycle of Sarcoptes Scabiei:
Infestation: The infestation occurs when a person comes into close contact with an
infested individual. Scabies is highly contagious, and transmission often occurs
through prolonged skin-to-skin contact.
Burrowing: The female mite burrows into the skin, creating characteristic
serpentine burrows, which are often visible as thin, grayish or brownish lines.
Egg Laying: The mite lays eggs within the burrow, and larvae hatch from these
eggs.
Development Stages: The larvae mature into nymphs and then into adult mites. The
entire life cycle typically takes about 2 to 4 weeks.

3. Host Immune Response

Inflammatory Response: The presence of mites and their activities within the skin
triggers an immune response, leading to inflammation and the characteristic
symptoms of scabies, including intense itching.
Hypersensitivity Reactions: Sensitization to mite antigens can result in delayed
hypersensitivity reactions, contributing to the inflammatory skin response.
4. Itching (Pruritus): The most common and characteristic symptom of scabies is
severe itching, often more pronounced at night.
5. Skin Lesions: The burrows created by the mites, along with scratching, lead to
the development of papules, vesicles, pustules, and crusted lesions.
6. Complications:
Secondary Infections: Scratching the affected areas can lead to breaks in the skin,
creating openings for bacterial infections. Bacterial superinfections can complicate
the condition.
7. Epidemiological Factors
Crowded Living Conditions: Scabies tends to be more prevalent in situations where
people live in close quarters, such as crowded households, institutions, and
healthcare facilities.
Close Personal Contact: The mites spread primarily through direct, prolonged skin
contact. Understanding the etiopathogenesis of scabies is crucial for effective
management and prevention. Treatment typically involves the use of scabicidal
medications to eliminate the mites, and it may also include measures to control the
spread of the infestation in communities and institutions. Personal hygiene, prompt
diagnosis, and appropriate treatment are essential components of scabies
management.
10.3.3 Clinical Manifestations
Scabies is characterized by a range of clinical manifestations primarily resulting
from the infestation of the skin by the Sarcoptes scabiei mite. The symptoms and
signs of scabies can vary from person to person, and the severity of the infestation
may influence the presentation.
Here are the typical clinical manifestations of scabies:
1. Intense Itching (Pruritus): One of the hallmark symptoms of scabies is intense
itching, which is often worse at night.
Itching is a result of the host's immune response to the presence of mites, their eggs,
and feces in the skin.
2. Skin Lesions:
Burrows: The female mite burrows into the skin to create characteristic serpentine
or wavy lines. These burrows are often visible as thin, grayish or brownish lines on
the skin, especially in areas with thin skin such as the webbing between fingers,
wrists, elbows, and genitals.
Papules and Pustules: In addition to burrows, small, red, or inflamed papules and
pustules may develop, especially in areas with a higher mite concentration.
3. Distribution of Lesions:
Interdigital Spaces: The spaces between the fingers are commonly affected, and
burrows may be evident in these areas.
Wrists and Elbows: Scabies lesions often appear on the wrists and elbows.
Axillae: The armpits may be affected.
Genitalia: In males, the genital region, including the penis and scrotum, may be
involved.
Areolae and Nipples: In females, the areolae and nipples may be affected.
4. Crusted (Norwegian) Scabies: In severe cases, especially in individuals with
compromised immune systems, scabies can manifest as crusted or Norwegian
scabies.
Crusted scabies is characterized by thick, crusted, and scaly lesions. The number of
mites in crusted scabies is significantly higher than in typical cases.
5. Secondary Infections: Scratching the affected areas can lead to breaks in the skin,
increasing the risk of bacterial infections.
Secondary infections can cause additional symptoms such as redness, warmth, and
pus formation.
10.3.4. Diagnosis of Scabies
Scabies is a skin infestation caused by the
Sarcoptes scabiei mite. It is a contagious
condition characterized by intense itching
and a pimple-like rash. Diagnosis of
scabies typically involves a combination
of clinical examination, patient history,
and sometimes additional tests. Here are
the key steps in diagnosing scabies:
1. Clinical Examination:
Skin Inspection: A healthcare professional, often a dermatologist, will examine the
affected areas of the skin. Scabies commonly affects areas such as the wrists,
elbows, armpits, genitals, and webbing between the fingers.
Characteristic Signs: The healthcare provider will look for typical signs of scabies,
such as small, red bumps, burrows (thin, grayish, or brownish lines on the skin),
and the presence of vesicles or pustules.
2. Patient History:
Symptoms: The doctor will inquire about symptoms, such as itching, especially at
night, which is a hallmark of scabies.
Exposure: Information about recent close contacts with individuals diagnosed with
scabies is crucial, as scabies is highly contagious.
3. Additional Tests:
Skin Scrapings: In some cases, the healthcare provider may perform a skin
scraping. This involves taking a small sample of the skin from the affected area and
examining it under a microscope to identify the presence of mites, eggs, or fecal
matter. This test is known as a microscopic examination of skin scrapings.
Dermoscopy: Dermoscopy is a non-invasive technique that uses a specialized
magnifying lens to examine the skin. It can help in visualizing characteristic
features of scabies.
10.3.5 Nonpharmacological and pharmacological management
The management of scabies involves both nonpharmacological and
pharmacological approaches. Scabies is primarily treated with scabicidal
medications to eliminate the mites, but additional measures are often necessary to
control the spread of the infestation and manage associated symptoms. Here's an
overview of nonpharmacological and pharmacological management strategies:
✓ Nonpharmacological Management:
1. Personal Hygiene:
Regular Bathing: Keeping the body clean through regular bathing can help reduce
the number of mites on the skin.
2. Avoiding Close Contact:
Isolation: Individuals with scabies should avoid close skin-to-skin contact with
others to prevent the spread of the infestation.
3. Cleaning and Disinfection:
Bedding and Clothing: Laundering and drying bedding, clothing, and personal
items at high temperatures can help kill mites and reduce the risk of reinfestation.
Personal Items: Avoid sharing personal items such as towels, clothing, and bed
linens.
4. Environmental Measures:
Vacuuming: Vacuuming living areas can help remove mites from the environment.
Hot Water Treatment: Items that cannot be laundered, such as stuffed animals, can
be sealed in plastic bags for several days or exposed to high temperatures to kill
mites.
✓ Pharmacological Management:
1. Topical Scabicidal Medications:
Permethrin Cream: Permethrin is a common first-line treatment. It is a topical
cream applied to the entire body and washed off after a specified time.
Ivermectin Cream: Ivermectin is another topical option that may be prescribed in
some cases.
2. Oral Medications:
Ivermectin Tablets: In cases of severe or crusted scabies, oral ivermectin may be
prescribed. This medication is taken orally and works systemically to kill the mites.
3. Antihistamines:
For Itching: Antihistamines may be recommended to alleviate itching. Common
options include diphenhydramine or loratadine.
4. Corticosteroid Creams:
For Inflammation: Topical corticosteroid creams may be prescribed to reduce
inflammation and relieve itching. These are typically used in combination with
scabicidal treatments.
5. Treatment of Secondary Infections:
Antibiotics: If bacterial infections occur as a result of scratching, antibiotics may be
prescribed.
6. Crusted Scabies Management:
Intensive Treatment: Crusted scabies may require more aggressive and prolonged
treatment with multiple doses of scabicidal medications.
10.4 ECZEMA
10.4.1 Introduction
Eczema, also known as dermatitis, refers to
a group of inflammatory skin conditions
characterized by redness, itching, and the
formation of small, fluid-filled blisters. The
term "eczema" is often used broadly to
describe various types of skin
inflammation, and there are several
different forms of eczema with distinct
causes and manifestations.
Key features of eczema include:
1. Inflammation: Eczema involves inflammation of the skin,
leading to redness, swelling, and heat in the affected areas.
2. Itching (Pruritus): Persistent and intense itching is a common
symptom of eczema. Scratching can exacerbate the condition and
may lead to the development of lesions.
5. Skin Rash: Eczema often presents as a rash, which can take
different forms depending on the specific type of eczema. The
rash may include red or brownish patches, blisters, dry and scaly
skin, or areas of oozing and crusting.
4. Chronic or Recurrent Nature: Eczema can be a chronic condition with periods of
exacerbation and remission. Individuals with eczema may experience flare-ups
triggered by various factors, such as stress, certain foods, environmental irritants, or
allergens.
Various Types of Eczema:
Atopic Dermatitis: A common form of eczema associated with a predisposition to
allergies, often seen in individuals with a family history of allergic conditions.
Contact Dermatitis: Caused by contact with irritants or allergens, resulting in
localized inflammation.
Nummular Dermatitis: Characterized by coin-shaped patches of irritated skin.
Seborrheic Dermatitis: Affecting areas with a high concentration of oil glands, such
as the scalp, face, and chest.
Dyshidrotic Eczema: Involving the formation of small blisters on the palms of the
hands and soles of the feet.
Varying Severity: Eczema can range from mild,
with occasional itching and redness, to severe
cases that significantly impact the quality of life.
Management of eczema typically involves a
combination of skincare practices, avoiding
triggers, and, in some cases, the use of topical
corticosteroids or other medications to reduce
inflammation and alleviate symptoms.
10.4.2 Etiopathogenesis of Eczema
The etiopathogenesis of eczema, also known as dermatitis, is complex and involves
a combination of genetic, immunological, environmental, and lifestyle factors.
Eczema is not a single disease but a term that encompasses various types of
inflammatory skin conditions, each with its own set of contributing factors. The
primary types of eczema include atopic dermatitis, contact dermatitis, seborrheic
dermatitis, and nummular dermatitis. Here are key aspects of the etiopathogenesis
of eczema:
1. Genetic Factors (Atopic Dermatitis):
Atopic Predisposition: Atopic dermatitis, a common form of eczema, often occurs
in individuals with a genetic predisposition to allergic conditions such as asthma,
hay fever, and eczema. There is a strong familial association.
2. Immune System Dysregulation:
Immunological Abnormalities: Eczema is associated with immune system
dysregulation, leading to an exaggerated inflammatory response in the skin.
Abnormalities in immune cells, such as T cells and dendritic cells, play a role in the
development of eczematous lesions.
3. Skin Barrier Dysfunction:
Impaired Skin Barrier: Individuals with eczema often have a compromised skin
barrier, allowing irritants, allergens, and microorganisms to penetrate the skin more
easily. This can lead to increased susceptibility to inflammation.
4. Environmental Factors:
Allergens and Irritants: Exposure to allergens (substances that trigger an allergic
response) and irritants can contribute to the development of eczema. Common
allergens include certain foods, pollen, pet dander, and dust mites. Irritants may
include harsh soaps, detergents, and chemicals.
5. Microbial Factors:
Microbial Colonization: Abnormal colonization of the skin by bacteria, fungi, or
viruses may contribute to the inflammation seen in eczema. Staphylococcus aureus,
in particular, is often associated with eczematous lesions.
6. Environmental Triggers:
Climate and Environmental Conditions: Changes in climate, humidity, and
exposure to extremes of temperature can trigger or exacerbate eczema symptoms.
7. Stress and Psychological Factors:
Psychological Stress: Stress and emotional factors can influence the severity and
course of eczema. Stress management and psychological well-being may play a role
in managing the condition.
8. Individual Susceptibility:
Individual Variation: Each person's response to environmental factors and triggers
can vary, and some individuals may be more susceptible to certain exacerbating
factors than others.
10.4.3 Clinical manifestations
The clinical manifestations of eczema (dermatitis) can vary depending on the
specific type of eczema and the individual's characteristics. Different types of
eczema may present with distinct features, but there are common symptoms that are
often associated with eczematous conditions. Here are the key clinical
manifestations:
1. Redness and Inflammation: Eczematous skin typically appears red and inflamed.
The inflammation is a result of the immune response and may be more pronounced
during flare-ups.
2. Itching (Pruritus): Itching is a hallmark symptom of eczema and can be intense.
The urge to scratch can lead to further irritation and may contribute to the
development of lesions.
3. Rash and Lesions: The rash associated with eczema may present in various
forms, including:
• Papules: Small, raised bumps on the skin.

• Vesicles: Fluid-filled blisters that may ooze and form crusts.

• Pustules: Small, pus-filled bumps.

• Erosions: Areas where the skin has worn away.

• Cracks: Fissures in the skin, especially common in areas with repeated

movement.
4. Dry and Scaly Skin: Eczema often results in dry, scaly skin, particularly during
periods of remission. The skin may feel rough and may be more prone to cracking.
5. Flexural Involvement (Atopic Dermatitis): Atopic dermatitis, a common type of
eczema, often affects flexural areas, such as the insides of the elbows and behind
the knees. The skin in these areas may be more susceptible to irritation.
6. Distribution of Lesions: The distribution of eczema lesions can vary based on the
type of eczema. For example:
• Atopic dermatitis often affects the face, neck, hands, and flexural areas.

• Contact dermatitis may be localized to areas exposed to irritants or allergens.

• Seborrheic dermatitis commonly affects the scalp, face, and chest.

7. Nummular (Coin-Shaped) Eczema Lesions: Nummular dermatitis is

characterized by circular or coin-shaped lesions. These may be more prone to
crusting and scaling.
8. Prone to Secondary Infections: Scratching and breaks in the skin can make
individuals with eczema more susceptible to bacterial, fungal, or viral infections.
9. Chronic or Recurrent Nature: Eczema is often a chronic condition with periods of
exacerbation and remission. Some individuals may experience recurrent flare-ups
triggered by specific factors.
10. Psychosocial Impact: Living with eczema can have psychosocial implications,
as the persistent itching and visible skin changes may affect an individual's quality
of life, self-esteem, and emotional well-being.
10.4.4 Diagnosis of Eczema
The diagnosis of eczema (dermatitis) involves a thorough clinical examination,
medical history assessment, and, in some cases, additional tests. There isn't a
specific laboratory test that can definitively diagnose eczema; instead, healthcare
providers rely on a combination of factors to make an accurate diagnosis. Here are
the key steps in the diagnosis of eczema:
1. Clinical Examination:
Physical Assessment: A healthcare professional, often a dermatologist, will
examine the affected areas of the skin. They will look for specific characteristics
such as redness, swelling, rash, and patterns of skin lesions.
Distribution of Lesions: Eczema lesions often have a characteristic distribution,
depending on the type of eczema. For example, atopic dermatitis tends to affect
flexural areas (inside the elbows and behind the knees), while contact dermatitis
may be localized to areas in contact with irritants or allergens.
2. Patient History:
Symptoms: The doctor will inquire about symptoms, such as itching, redness, and
the appearance of the rash.
Onset and Duration: Information about when the symptoms began and their
duration can help in understanding the course of the condition.
Triggers: Identifying potential triggers, such as exposure to certain substances or
environmental factors, is essential.
3. Exclusion of Other Conditions: The healthcare provider may need to exclude
other skin conditions that may have similar symptoms. Conditions such as
psoriasis, fungal infections, and allergic reactions can sometimes mimic eczema.
4. Patch Testing (For Contact Dermatitis): In cases where contact dermatitis is
suspected, patch testing may be conducted to identify specific allergens that trigger
the skin reaction.
5. Skin Biopsy (Rarely): In certain situations where the diagnosis is unclear or
when there is a need to rule out other skin disorders, a skin biopsy may be
performed. However, this is not commonly required for typical cases of eczema.
6. Follow-Up and Monitoring: The healthcare provider may recommend follow-up
appointments to monitor the progression of the condition, assess the response to
treatment, and make any necessary adjustments to the management plan.
10.4.5 Nonpharmacological and pharmacological management
The management of eczema involves a combination of nonpharmacological
(lifestyle and skincare practices) and pharmacological (medication-based)
approaches. The goal is to control inflammation, alleviate symptoms, prevent flare-
ups, and improve the overall quality of life for individuals with eczema. Here's an
overview of both nonpharmacological and pharmacological management strategies:
✓ Nonpharmacological Management:
1. Skin Care Practices:
Regular Moisturization: Applying moisturizers helps maintain the skin barrier and
prevent dryness. Emollients or ointments are often preferred over lotions.
Avoiding Harsh Soaps: Use mild, fragrance-free soaps and avoid products
containing harsh chemicals that may irritate the skin.
Short, Lukewarm Baths: Limiting bath time and using lukewarm water can help
prevent excessive drying of the skin.
2. Identifying and Avoiding Triggers:
Allergen Avoidance: If specific allergens are identified, efforts should be made to
avoid them. This may involve changes in diet, household products, or
environmental factors.
Irritant Avoidance: Identifying and avoiding irritants, such as certain fabrics or
chemicals, can help prevent flare-ups.
3. Appropriate Clothing:
Cotton Clothing: Wearing loose-fitting, breathable cotton clothing can reduce
irritation.
Avoiding Wool and Synthetic Fabrics: Fabrics like wool and synthetics can
sometimes worsen symptoms.
4. Climate and Environmental Considerations:
Humidifiers: Using humidifiers in dry environments can help maintain skin
moisture.
Temperature Control: Avoiding extremes of temperature and humidity may be
beneficial.
5. Stress Management:
Stress Reduction Techniques: Stress can exacerbate eczema symptoms. Practices
such as meditation, yoga, and mindfulness may help manage stress.
✓ Pharmacological Management:
1. Topical Corticosteroids:
Anti-Inflammatory: Topical corticosteroids are commonly used to reduce
inflammation and itching. They come in varying strengths, and the choice depends
on the severity and location of the eczema.
2. Topical Calcineurin Inhibitors:
Alternative to Corticosteroids: In cases where corticosteroids may not be suitable,
topical calcineurin inhibitors like tacrolimus or pimecrolimus may be used to
control inflammation.
3. Topical Phosphodiesterase-4 (PDE4) Inhibitor:
Crisaborole: This is a nonsteroidal topical medication that can be used for mild to
moderate eczema.
4. Systemic Medications:
Oral Antihistamines: Used to relieve itching. Non-sedating antihistamines are often
preferred.
Oral Corticosteroids: In severe cases, a short course of oral corticosteroids may be
prescribed to rapidly control inflammation. However, long-term use is generally
avoided due to potential side effects.
Immunomodulators: In specific cases, systemic immunomodulators like
cyclosporine or methotrexate may be considered.
5. Biologic Therapies (For Severe Cases):
Dupilumab: A biologic medication that targets specific components of the immune
system. It is used for moderate to severe atopic dermatitis not adequately controlled
by other treatments.
6. Wet Wrap Therapy:
Hydration and Occlusion: In some cases, wet wrap therapy involving the
application of wet bandages over moisturizers or medications can be used to
enhance hydration and penetration of topical treatments.